Marketing Collaboration Including Localization of Key Brands

Daewoong Pharmaceutical announced on June 9 that it has signed a Memorandum of Understanding (MOU) with the Indonesian Pharmacists Association (IAI) to establish a long-term cooperation framework, including strengthening pharmacist expertise.


Through this agreement, the two parties plan to collaborate in the following areas: pharmacist education and professional development; academic and expert cooperation; public health and disease management; and localization of pharmaceuticals and development of healthcare models.


Lilik, Secretary General of the Indonesian Pharmacists Association (left), and Eun Kyung Park, Head of the CH Division at Daewoong Pharmaceutical, are commemorating the signing of a Memorandum of Understanding (MOU). Daewoong Pharmaceutical

Lilik, Secretary General of the Indonesian Pharmacists Association (left), and Eun Kyung Park, Head of the CH Division at Daewoong Pharmaceutical, are commemorating the signing of a Memorandum of Understanding (MOU). Daewoong Pharmaceutical

View original image

First, they will operate customized educational programs for local pharmacists. The programs will offer lectures focusing on the latest pharmaceutical trends and disease management, enabling pharmacists to provide patient-centered medication counseling. In addition, they plan to share the results of their collaboration and healthcare content through their official website and social media channels.


The two organizations will jointly operate a local pharmacist expert council to provide pharmaceutical planning tailored to consumer characteristics and to offer brand consulting. Daewoong Pharmaceutical intends to localize its brands such as Easyderm, Impactamin, and EzN6 to fit the Indonesian market through this council. The company will incorporate feedback from local experts at the product planning and marketing stages to establish a healthcare model suited to local needs.



Daewoong Pharmaceutical aims to become the number one player in the Indonesian over-the-counter (OTC) pharmaceutical market by 2030 through this cooperation.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing